BioNTech aims to develop mRNA-based malaria vaccine | COVID-19 Special

3 monate vor


Tiny mosquitoes are the deadliest creatures on earth, when they transmit malaria. More than 200 million people are infected with malaria each year, according to the World Health Organisation and - as we've seen - around 400,000 of them die. Around two thirds are children under five. Doctors have long hoped for an effective vaccine. Now, thanks to coronavirus research, an end to malaria could be in sight. Researchers are developing a vaccine to stop malaria using the same breakthrough mRNA technology that proved so successful in coronavirus vaccines. Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1 For more news go to: http://www.dw.com/en/ Follow DW on social media: ►Facebook: https://www.facebook.com/deutschewellenews/ ►Twitter: https://twitter.com/dwnews ►Instagram: https://www.instagram.com/dwnews Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch #Covid19 #Malaria #BioNTech
Aus der Quelle lesen